Logo image of PHXM

PHAXIAM Therapeutics SA (PHXM) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:PHXM - US29604W2070 - ADR

3.1 USD
-0.02 (-0.64%)
Last: 3/8/2024, 8:27:22 PM
3.1 USD
0 (0%)
After Hours: 3/8/2024, 8:27:22 PM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to PHXM. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 10.17. This target is 228.04% above the current price.
  • PHXM was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PHXM.
  • In the previous month the buy percentage consensus was at a similar level.
  • PHXM was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

PHXM Historical Analyst RatingsPHXM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 3.108.3910.1710.1712.21 - 170.69% 228.04% 228.04% 293.97%

Related screens

PHXM Current Analyst RatingPHXM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

PHAXIAM Therapeutics SA / PHXM FAQ

What is the price target for PHXM stock?

8 analysts have analysed PHXM and the average price target is 10.17 USD. This implies a price increase of 228.04% is expected in the next year compared to the current price of 3.1.


How do analysts rate PHAXIAM Therapeutics SA (PHXM)?

The consensus rating for PHAXIAM Therapeutics SA (PHXM) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed PHAXIAM Therapeutics SA (PHXM)?

The number of analysts covering PHAXIAM Therapeutics SA (PHXM) is 8.